Matthew M. Gosling, Senior VP, General Counsel at DEPOMED INC (DEPO), sold 5,692 shares at $8.40 ($48K) on 2013-12-02, disclosed to the SEC on 2013-12-04.
Scheduled sale ($48k) by Senior VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DEPO | SELL | 2017-05-15 | $1.3M | — | Filing → |
| DEPO | SELL | 2014-12-03 | $140K | — | Filing → |
| DEPO | SELL | 2014-11-21 | $1.1M | — | Filing → |